Medical Devices Pharmaceuticals Vaccines Medical Procedures Medical Diagnostic Equipments Digital Medicine Public health policy
Medical Devices Pharmaceuticals Vaccines Medical Procedures Medical Diagnostic Equipments Digital Medicine Public health policy

Policy Brief

Our Policy Brief presents research in a clear, concise, and engaging format, designed to support high-level executives and policy decision-makers in using evidence-based information to inform effective policy development and implementation.
Health Policies Pharmaceuticals Vaccines Medical Devices Medical Procedures Medical Innovation Early HTA Equality Greenhouse Gases PM2.5 AI Telemedicine
No information found
Highlight Policy Brief

No information found

Policy Brief 56 issues
All (56)
Rare diseases – Talk of the Town for Some Time but What’s Next?
Issue No. 26
Rare diseases – Talk of the Town for Some Time but What’s Next?
By : Phornnaphat Chertchinnapa, Annapoorna Prakash
South Korea’s Experience of Reimbursing High-Cost Medicines
Issue No. 25
South Korea’s Experience of Reimbursing High-Cost Medicines
By : Dr. Dimple Butani
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
Issue No. 24
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
By : Kumaree Pachanee, Dian Faradiba
Health Financing during COVID-19 responses in Thailand
Issue No. 149
Health Financing during COVID-19 responses in Thailand
By : Papada Ranron, Praewa Kulatnam, Aungsumalee Pholpark, Sikarn lssarachaiyos
Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
Issue No. 23
Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
By : Dian Faradiba
Horizon Scanning in the European Union
Issue No. 22
Horizon Scanning in the European Union
By : Dian Faradiba, Dr. Dimple Butani, Mr. Nyi Nyi Zayar
The Life Saving Drug Program: Australia’s pathway to high-cost drugs
Issue No. 21
The Life Saving Drug Program: Australia’s pathway to high-cost drugs
By : Evan Huang-Ku, Dr. Tracey Laba
Unpacking Digital Health: A breakdown of concepts and definitions
Issue No. 145
Unpacking Digital Health: A breakdown of concepts and definitions
By : Dr. Dimple Butani
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
Issue No. 142
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
By : Wanrudee Isaranuwatchai, PhD, Picharee Karunayawong, Dr. Piyada Gaewkhiew, Chulathip Boonma, Myka Harun Sarajan
Distributing ‘Smart Watch’ alone cannot reduce Sedentary Behavior. An Active Lifestyle can be encouraged by harmonizing Individual, Social, Organizational, and Environmental levels.
Issue No. 121
Distributing ‘Smart Watch’ alone cannot reduce Sedentary Behavior. An Active Lifestyle can be encouraged by harmonizing Individual, Social, Organizational, and Environmental levels.
By : Katika Akksilp, M.D.
Preliminary recommendations on the establishment of a regional centre for infectious disease control in ASEAN
Issue No. 99
Preliminary recommendations on the establishment of a regional centre for infectious disease control in ASEAN
By : Yot Teerawattananon, PhD., Manit Sittimart, Aparna Ananthakrishnan
Which investment on interventions against COVID-19 pandemic is worth its cost?
Issue No. 20
Which investment on interventions against COVID-19 pandemic is worth its cost?
By : Amanuel Yigezu, Mezgebu Yitayal, Alemnesh H. Mirkuzie, Zekarias Getu, Alemayehu Hailu
12 / Pages
12345